Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer
Completed
National Cancer Institute (NCI)
Phase 2
1999-05-01
RATIONALE: Biological therapy using growth factors may be effective in reducing side effects
in patients who have hematologic cancer and are receiving radiation therapy, chemotherapy,
and peripheral stem cell transplantation.
PURPOSE: Randomized phase II trial to study the effectiveness of biological therapy to reduce
side effects in patients who are undergoing radiation therapy, chemotherapy, and peripheral
stem cell transplantation in treating lymphoma or leukemia.
Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer
Completed
Memorial Sloan Kettering Cancer Center
Phase 2
1999-05-01
RATIONALE: Biological therapy using growth factors may be effective in reducing side effects
in patients who have hematologic cancer and are receiving radiation therapy, chemotherapy,
and peripheral stem cell transplantation.
PURPOSE: Randomized phase II trial to study the effectiveness of biological therapy to reduce
side effects in patients who are undergoing radiation therapy, chemotherapy, and peripheral
stem cell transplantation in treating lymphoma or leukemia.
Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer
Completed
National Cancer Institute (NCI)
Phase 2
2000-01-01
RATIONALE: Keratinocyte growth factor may prevent symptoms of mucositis in patients receiving
radiation therapy and chemotherapy.
PURPOSE: Randomized phase II trial to study the effectiveness of keratinocyte growth factor
in preventing oral mucositis in patients who have hematologic cancers and who are undergoing
radiation therapy and chemotherapy before autologous peripheral stem cell transplantation.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
